The report of increased expression of CD8+ T cell granzyme b, IFNγ, and TNFα in the peripheral blood of lung transplant patients many months before a fall in lung function and subsequent diagnosis of BOS points to possibly the best biomarkers to date to predict impending chronic allograft rejection [38,39]. The gene discussed is GZMB; the disease is Buschke-Ollendorff syndrome.